Diagnosis and management of moderate to severe adult atopic dermatitis: a Consensus by the Italian Society of Dermatology and Venereology (SIDeMaST), the Italian Association of Hospital Dermatologists (ADOI), the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC), and the Italian Society of Allergological, Environmental and Occupational Dermatology (SIDAPA)-Reference-Cited by-同舟云学术

Diagnosis and management of moderate to severe adult atopic dermatitis: a Consensus by the Italian Society of Dermatology and Venereology (SIDeMaST), the Italian Association of Hospital Dermatologists (ADOI), the Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC), and the Italian Society of Allergological, Environmental and Occupational Dermatology (SIDAPA)

Published:2018-03 Issue:2 Volume:153 Page:
ISSN:2784-8671
Container-title:Italian Journal of Dermatology and Venereology
language:
Short-container-title:Ital J Dermatol Venereol

Author:

Calzavara Pinton Piergiacomo,Cristaudo Antonio,Foti Caterina,Canonica Giorgio W.,Balato Nicola,Costanzo Antonio,De Pità Ornella,De Simone Clara,Patruno Cataldo,Pellacani Giovanni,Peris Ketty,Girolomoni Giampiero

Publisher

Edizioni Minerva Medica

Subject

Infectious Diseases,Dermatology

Link

https://www.minervamedica.it/pdf.php?cod=R23Y2018N02A0133

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Italian healthcare resource consumptions and direct costs of adults with atopic dermatitis before and after dupilumab treatment;Italian Journal of Dermatology and Venereology;2024-07

2. Cost per NNT for upadacitinib in the treatment of patients with moderate-severe atopic dermatitis in Italy;Global and Regional Health Technology Assessment;2024-02-16

3. Multi-dimensional evaluation of dupilumab efficacy in atopic dermatitis patients with a high disease;Italian Journal of Dermatology and Venereology;2024-02

4. Efficacy and Safety of Dupilumab in Chinese Elderly Patients with Atopic Dermatitis: A Real-World Study;Dermatology;2024

5. Ultra-High Frequency UltraSound (UHFUS) Assessment of Barrier Function in Moderate-to-Severe Atopic Dermatitis during Dupilumab Treatment;Diagnostics;2023-08-22